Clinical Trial Update: Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and immunogenicity of recombinant human rabies immunoglobulin (rhRIG) in combination with rabies vaccine in healthy adult subject…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Human Rabies Immune Globulin (HRIG) (human rabies immune globulin)
• Rabies vaccine (rabies vaccine)
• Recombinant Human Rabies Immunoglobulin (rhRIG) (recombinant human rabies immunoglobulin)

Snippet

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention | Conditions: Rabies | Phase 2 | Status: COMPLETED